Scientific World Model

The world's most comprehensive mechanistic knowledge base for neurodegenerative diseases.

17,524 pages — genes, proteins, mechanisms, therapeutics, and more

What is the Scientific World Model?

Our AI agents have synthesized 17,000+ wiki-style pages covering every major entity, mechanism, and therapeutic avenue in neurodegeneration research. Each page is automatically generated and continuously updated from the latest scientific literature, connecting genes like APOE and MAPT to pathways, proteins, and disease mechanisms.

This forms a living knowledge graph that powers our hypothesis generation, therapeutic target identification, and research gap analysis. Browse by entity type below or search for any gene, protein, mechanism, or drug.

All (17,524)🧬 gene (3,874)🔬 cell (3,397)🔬 protein (3,107)⚙️ mechanism (1,789)💊 therapeutic (1,028)🏢 company (643)🏥 disease (501)🧪 clinical (392)🏛️ institution (308)👤 researcher (214)💡 idea (200)↪️ redirect (184)📊 biomarker (182)🧫 experiment (161)🔧 technology (151) general (151) ai_tool (142) entity (114)
Showing 1–50 of 1,028 pages

💊 cbs-psp-daily-action-planKG

therapeutic · 30,834 words · 46 hyp22 ana46 exp

💊 Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)KG

therapeutic · 15,794 words · 31 hyp20 ana39 exp

💊 AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery AlternativesKG

therapeutic · 15,567 words · 65 hyp27 ana25 exp

💊 Clinical Management Guide for CBS/PSPKG

therapeutic · 15,224 words · 5 hyp10 ana30 exp

💊 CBS/PSP Supplements GuideKG

therapeutic · 6,929 words · 11 hyp11 ana38 exp

💊 Device Therapies Comparison for CBS/PSPKG

therapeutic · 6,867 words · 18 hyp9 ana17 exp

💊 CBS/PSP Rehabilitation Master GuideKG

therapeutic · 6,539 words · 4 hyp7 ana31 exp

💊 Section 148: Advanced Nutritional Biochemistry in CBS/PSPKG

therapeutic · 6,350 words · 20 hyp15 ana23 exp

💊 Section 162: Advanced Antioxidant and Redox Therapy in CBS/PSPKG

therapeutic · 5,600 words · 63 hyp27 ana32 exp

💊 CBS/PSP Treatment RankingsKG

therapeutic · 5,434 words · 20 hyp10 ana23 exp

💊 coq10-neurodegenerationKG

therapeutic · 5,142 words · 282 hyp53 ana57 exp

💊 Growth Factor TherapiesKG

therapeutic · 4,974 words · 114 hyp57 ana9 exp

💊 CBS/PSP Clinical Trials GuideKG

therapeutic · 4,969 words · 12 hyp4 ana53 exp

💊 rasagilineKG

therapeutic · 4,916 words · 4 hyp4 ana

💊 omega-3-fatty-acids-neurodegenerationKG

therapeutic · 4,551 words · 283 hyp55 ana83 exp

💊 Melatonin for Tauopathy: Comprehensive Evidence SynthesisKG

therapeutic · 4,539 words · 34 hyp39 ana26 exp

💊 protective-strategies-cbs-pspKG

therapeutic · 4,501 words · 17 hyp14 ana27 exp

💊 Sulforaphane and Nrf2 Activation for NeuroprotectionKG

therapeutic · 4,477 words · 22 hyp22 ana7 exp

💊 Coenzyme Q10 for NeurodegenerationKG

therapeutic · 4,452 words · 281 hyp53 ana58 exp

💊 deferiprone-neurodegenerationKG

therapeutic · 4,392 words · 282 hyp53 ana58 exp

💊 Section 152: Advanced Robotics and Assistive Devices in CBS/PSPKG

therapeutic · 4,341 words · 19 hyp7 ana17 exp

💊 lithium-tauopathyKG

therapeutic · 4,282 words · 5 hyp7 ana3 exp

💊 Section 147: Telehealth and Remote Monitoring in CBS/PSPKG

therapeutic · 4,197 words · 23 hyp8 ana15 exp

💊 cognitive-reserve-cbs-pspKG

therapeutic · 4,179 words · 18 hyp9 ana17 exp

💊 vitamin-d-therapy-neurodegenerationKG

therapeutic · 4,119 words · 291 hyp57 ana61 exp

💊 Neuroprotection Strategies in NeurodegenerationKG

therapeutic · 4,093 words · 306 hyp57 ana71 exp

💊 NACET (N-Acetylcysteine Ethyl Ester)KG

therapeutic · 4,082 words · 1 hyp4 ana4 exp

💊 Curcumin for NeurodegenerationKG

therapeutic · 4,017 words · 289 hyp59 ana58 exp

💊 Mediterranean and MIND Diets for NeurodegenerationKG

therapeutic · 4,008 words · 281 hyp53 ana55 exp

💊 creatine-supplementation-neurodegenerationKG

therapeutic · 3,971 words · 279 hyp54 ana58 exp

💊 Section 153: Virtual Reality Therapy Protocols in CBS/PSPKG

therapeutic · 3,953 words · 60 hyp24 ana15 exp

💊 Section 233: Advanced Virtual Reality and Immersive Technology-Based Rehabilitation in CBS/PSPKG

therapeutic · 3,946 words · 6 hyp9 ana14 exp

💊 Ambroxol for Neurodegeneration (GCase Chaperone Strategy)KG

therapeutic · 3,919 words · 281 hyp53 ana55 exp

💊 Bepranemab (UCB0107)KG

therapeutic · 3,880 words · 13 hyp6 ana6 exp

💊 Nanomedicine Approaches to Alzheimer's DiseaseKG

therapeutic · 3,864 words · 48 hyp31 ana54 exp

💊 rapamycin-tauopathyKG

therapeutic · 3,805 words · 52 hyp42 ana8 exp

💊 NAD+ Precursors for NeurodegenerationKG

therapeutic · 3,785 words · 290 hyp57 ana73 exp

💊 O-GlcNAcase (OGA) Inhibitor Landscape — Programs, Mechanisms, CompaniesKG

therapeutic · 3,763 words · 7 hyp34 ana7 exp

💊 Creatine for NeuroprotectionKG

therapeutic · 3,742 words · 3 hyp4 ana4 exp

💊 Exosome and Extracellular Vesicle Brain DeliveryKG

therapeutic · 3,732 words · 184 hyp67 ana10 exp

💊 tudca-udca-neurodegenerationKG

therapeutic · 3,718 words · 283 hyp53 ana60 exp

💊 nfl-blood-test-guided-therapyKG

therapeutic · 3,716 words · 60 hyp25 ana22 exp

💊 Parkinson's Disease TreatmentKG

therapeutic · 3,641 words · 6 hyp20 ana63 exp

💊 Circadian Rhythm Modulation TherapyKG

therapeutic · 3,566 words · 70 hyp47 ana13 exp

💊 entacaponeKG

therapeutic · 3,559 words · 1 hyp4 ana

💊 Section 156: Pet Therapy and Animal-Assisted Interventions in CBS/PSPKG

therapeutic · 3,527 words · 53 hyp28 ana16 exp

💊 Etalanetug (E2814)KG

therapeutic · 3,489 words · 15 hyp8 ana7 exp

💊 Longevity and Rejuvenation Therapies LandscapeKG

therapeutic · 3,483 words · 45 hyp34 ana17 exp

💊 glp1-receptor-agonistsKG

therapeutic · 3,450 words · 11 hyp12 ana7 exp

💊 alpha-lipoic-acid-neurodegenerationKG

therapeutic · 3,435 words · 281 hyp54 ana73 exp

Loading more wiki pages...